review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1097/BOR.0B013E3283474D62 |
P698 | PubMed publication ID | 21519268 |
P50 | author | Keertan Dheda | Q30111631 |
Madhukar Pai | Q30332033 | ||
Claudia Denkinger | Q87150820 | ||
Adithya Cattamanchi | Q91293754 | ||
Karen R Steingart | Q96216065 | ||
P2093 | author name string | Kevin L Winthrop | |
Rachel Smith | |||
P433 | issue | 4 | |
P921 | main subject | tuberculosis | Q12204 |
inflammation | Q101991 | ||
latent tuberculosis | Q4254929 | ||
P304 | page(s) | 377-384 | |
P577 | publication date | 2011-07-01 | |
P1433 | published in | Current Opinion in Rheumatology | Q15750473 |
P1476 | title | Interferon-γ release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders | |
P478 | volume | 23 |
Q48089791 | 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. |
Q41595608 | Assessment of tuberculosis infection during treatment with biologic agents in a BCG-vaccinated pediatric population |
Q36713075 | Clinical manifestation and risk factors of tuberculosis infection in Malaysia: case study of a community clinic |
Q95817572 | Comparison between the Interferon γ Release Assay-QuantiFERON Gold Plus (QFT-Plus)-and Tuberculin Skin Test (TST) in the Detection of Tuberculosis Infection in Immunocompromised Children |
Q55717140 | Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA. |
Q82563549 | Detection of latent tuberculosis infection in rheumatologic diseases before anti-TNFα therapy: tuberculin skin test versus IFN-γ assay |
Q41750909 | Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay |
Q41700011 | Diagnosis of latent tuberculosis infection with T-SPOT(®).TB in a predominantly immigrant population with rheumatologic disorders. |
Q64112187 | Diagnostic value of the interferon-γ release assay for tuberculosis infection in patients with Behçet's disease |
Q40282145 | Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease. |
Q84823754 | Early diagnosis and treatment of ankylosing spondylitis in Africa and the Middle East |
Q47119702 | Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy |
Q41686103 | Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents. |
Q37544916 | Gamma interferon release assays for detection of Mycobacterium tuberculosis infection |
Q36637982 | Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence |
Q38168914 | Interferon-gamma release assays for tuberculosis: current and future applications |
Q40159900 | Performance of QuantiFERON(®)-TB Gold In-Tube assay in children receiving disease modifying anti-rheumatic drugs |
Q37980410 | Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis. |
Q35154706 | QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment |
Q59032574 | Risk factors for tuberculosis |
Q39237874 | Screening of immigrants in the UK for latent tuberculosis |
Q38265740 | Screening of latent tuberculosis infection by interferon-γ release assays in rheumatic patients: a systemic review and meta-analysis |
Q59047425 | Targeted Screening for Latent TB Infection prior to Biologic Therapy to Improve Patient Safety and Reduce Costs: A Prospective Observational Study |
Q90256870 | The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection |
Q38102726 | Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: an Asian perspective. |
Search more.